Sign In
Buy INBS
$2.44
-0.100 (-3.94%)
At Close: Jun 03, 2026
CCC Intelligent Solutions Holdings Inc. (NYSE:CCCS) Given Average Rating of “Hold” by Brokerages
01:42am, Friday, 24'th Oct 2025
Shares of CCC Intelligent Solutions Holdings Inc. (NYSE: CCCS - Get Free Report) have earned a consensus rating of "Hold" from the six research firms that are currently covering the company, MarketBea
Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider
08:30am, Thursday, 23'rd Oct 2025
Multinational company employs approximately 3,000 staff within the UK and Ireland and more than 30,000 staff worldwide Large new customer account highlights accelerating adoption of the Company's rapi
CCC Intelligent Solutions (CCCS) to Release Quarterly Earnings on Thursday
01:50am, Thursday, 23'rd Oct 2025
CCC Intelligent Solutions (NYSE: CCCS - Get Free Report) will likely be issuing its results before the market opens on Thursday, October 30th. Analysts expect the company to announce earnings of $0.09
The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept. 26, 202
Intelligent Bio Solutions Provides Update on FDA 510(k) Clearance Process for Intelligent Fingerprinting Drug Screening System
08:30am, Wednesday, 17'th Sep 2025
NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing s
Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in July
08:30am, Tuesday, 19'th Aug 2025
Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growth Company reports all-time-high monthly cartridge sales for July with 60% year-on-year growth
Company advanced efforts to secure U.S. FDA 510(k) clearance to advance on path towards planned U.S. market expansion beyond Forensic Use Only settings
Intelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025
08:30am, Tuesday, 12'th Aug 2025
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing a
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and
Intelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market Launch
08:30am, Wednesday, 06'th Aug 2025
FDA response expected within six weeks; Company remains focused on 2025 U.S. expansion FDA response expected within six weeks; Company remains focused on 2025 U.S. expansion
Intelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport Operator
08:30am, Wednesday, 30'th Jul 2025
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing so
Intelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross Proceeds
08:30am, Friday, 25'th Jul 2025
Proceeds to Fund Completion of the Company's 510k Filing with the U.S. FDA for its Fingerprint Drug Screening System Proceeds to Fund Completion of the Company's 510k Filing with the U.S. FDA for its
Data confirms Company's ability to detect trace sweat volumes at ultra-micro level System demonstrates resilience across diverse conditions NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing so
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing so
